Investing

IPO Withdrawal: Codexis (PFE)

Codexis Inc. has filed with the SEC last night to withdraw its planned initial public offering.  Based in Redwood City, California, the company provides solutions for pharmaceutical chemical process development and manufacturing, The company has withdrawn its registration for an IPO of up to $100 million.  One interesting note is that this company is V.C.-backed and Pfizer Inc. (NYSE: PFE) is one of the V.C. investors via a collaboration pact.  Other investors are CCTV Investments, CMEA Ventures, Pequot Capital, and others.  Credit Suisse and Goldman Sachs were going to be co-lead underwriters.  You can guess the reasons behind this withdrawal: due to current public market conditions….

Jon C. Ogg
September 3, 2008

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.